CosmosID

Missed our live webinar last week with Britton Strickland, Ph.D. and Gustav Lindved? No worries! You can catch all the insights and expert tips on demand anytime thanks to our friends at Revvity. 🎥✨ Dive into the discussion and see what you missed! Watch it here: https://hubs.li/Q02XnvjS0 #WebinarOnDemand #LearnWithUs #microbiome #metagenomics #software

🎉 2 Exciting Announcements! We're thrilled to report the opening of our new US metabolomics laboratory and the expansion of our Short Chain Fatty Acid (SCFA) Panel! To celebrate, we're offering limited-time discounts on our expanded Short-Chain Fatty Acid (SCFA) Panel: 🌟Up to 20% off our SCFA panel for orders before year-end 🌟Up to 40% off the SCFA panel + metagenomics analysis combo Get in touch to take advantage of our offers: https://hubs.li/Q02XhfnL0 🔬 Our enhanced SCFA panel now includes groundbreaking new targets such as 3-Methyl pentanoic acid and 2-Methylbutyric acid (plus many more!), key in reducing inflammation and supporting cardiovascular health. The new additions to our panel, the branched short-chain fatty acids (BCFAs), are crucial for deepening our understanding of the gut microbiome's impact on overall health. These BCFAs, including 2-methylbutyric acid, play significant roles in reducing inflammation and oxidative stress, potentially lowering dementia risks and promoting cardiovascular health. By expanding your panel to include these BCFAs, your research into the intricate interplay between diet, microbiota, and host health becomes more detailed, empowering more precise studies into how the gut microbiome influences various health conditions. 🌍 Available now in both our EU and US facilities, seize this perfect opportunity to advance your microbiome research with cutting-edge precision at great discounts! #Metabolomics #MicrobiomeResearch #HealthInnovation #LabOpening #ScienceNews

🍿Join us on October 30th for a live demo of CosmosID-HUB 🍿 📊 What to Expect: - Learn how NEXTFLEX™ WGS library kit users can access complimentary analysis credits - Explore workflows like CHAMP for human microbiome research and Kepler for non-human/environmental studies - Gain insights into applications across clinical, environmental, and agricultural sectors, including poultry health - Explore More Q&A session In this session, we'll dive deep into the HUB’s intuitive interface and analytical capabilities. Speakers: 🧑🔬 Britton Strickland, Ph.D. (Field Application Scientist) 🧑🔬 Gustav Lindved (Senior Scientific Product Manager) Don’t miss out on this opportunity to see how advanced bioinformatics can unlock the full potential of your metagenomic data! Save your spot for October 30th now 👉https://hubs.li/Q02TdG170 #Bioinformatics #Metagenomics #Sequencing #ResearchInnovation #Webinar #MicrobiomeResearch

🍿Unlock The Full Potential Of Your Shotgun Metagenomic Sequencing Data! 🍿 Join us and our partners, Revvity, on October 30th for an insightful webinar on how to transform raw metagenomic sequencing data into meaningful insights using the CosmosID-HUB platform. Whether you’re in clinical, environmental, or agricultural research, this session is for you! 🎓What You’ll Learn 🎓 - Seamlessly explore and analyze your data with analysis credits for NEXTFLEX™ WGS library kit users. - Dive into specialized workflows like CHAMP for human microbiome research and KEPLER for environmental studies - Discover how the CosmosID-HUB’s advanced tools provide high-resolution taxonomic profiling, functional characterization, and cohort comparative analysis - Explore More Q&A session Speakers: 🧑🔬 Britton Strickland, Ph.D. (Field Application Scientist) 🧑🔬 Gustav Lindved (Senior Scientific Product Manager) Don’t miss out on this opportunity to see how advanced bioinformatics can unlock the full potential of your metagenomic data! Save your spot for October 30th now 👉https://hubs.li/Q02TdD6t0 #Bioinformatics #Metagenomics #Sequencing #ResearchInnovation #Webinar #MicrobiomeResearch

Exciting News!📰 Clinical Microbiomics is thrilled to announce a significant step in our global expansion. As part of a new agreement with Microba Life Sciences Ltd., Microba’s Research Services business unit will join the Clinical Microbiomics family. We are excited to bring our multi-omics services and integrative systems biology expertise to even more clients around the globe. Anders Grøn, CEO of Clinical Microbiomics: “Microba has built an excellent reputation and shares our commitment to scientific and quality excellence. This collaboration accelerates our expansion into Asia Pacific, allowing us to elevate the role of microbiome science across human and planetary health.” We are also pleased to welcome key Microba research services staff in Australia, Singapore, and Korea, providing local expertise to our clients in the region. Mark P., Director of Business Development APAC and Emerging Markets: “We are excited to bring Clinical Microbiomics’ state-of-the-art multi-omics laboratories, advanced bioinformatics, applied AI, and integrative systems biology expertise to our clients in the region. The strong scientific culture of Microba merges seamlessly with the professionalism and scientific rigor of our team.” Read more: https://lnkd.in/dvX6EeRX #GlobalExpansion #MicrobiomeScience #AsiaPacific #BiotechInnovation #ClinicalMicrobiomics

🌍🔬Emerging trends in the Microbiome for 2024! 🔬🌍 The microbiome industry is rapidly evolving, with groundbreaking trends and insights set to shape healthcare, agriculture, and nutrition in 2024 📈 At CosmosID, we've compiled 40 key statistics and trends that highlight the transformative impact of microbiome research. From novel therapeutic approaches to cutting-edge technological advancements, these insights will help you stay ahead in this dynamic field. 👉 Check out our latest blog post; 40 Microbiome Statistics and Trends Changing the Industry in 2024. https://hubs.li/Q02S7YkB0 #Microbiome #HealthcareInnovation #MicrobiomeResearch #CosmosID #BiotechTrends #MicrobiomeTherapeutics #2024Trends #LifeSciences #FutureOfHealthcare

Fast and cost-effective long-read sequencing of microbial genomes. Long-read nanopore sequencing has advanced significantly. Using the latest Q20+ chemistry, high-quality bacterial genomes are obtainable without short-read or reference-based polishing. These high-quality (QV50+) and contiguous genomes provide unprecedented biological insight, even across challenging regions like repetitive elements and structural variants. In a recent co-authored publication in Nature Methods (https://hubs.li/Q02R36S40), we demonstrate how Oxford Nanopore Technologies enables this leap forward. At Clinical Microbiomics / CosmosID/ DNASense, our sample-to-answer workflows cover: - DNA extraction, library preparation, sequencing and quality control - de novo genome assembly, functional gene annotation and whole-genome classification - Structural variation analysis, including repetitive and mobile elements - Core genome SNP analysis for ultra-high resolution phylogenetic comparisons - Methylation pattern analysis - GRAS regulatory genomic reporting for probiotic strains Our genomics service offers fast turnaround time (down to 72 h) and unmatched accuracy, making it the ideal choice for research and regulatory applications. Contact us to learn how our long-read sequencing solutions can accelerate your microbial genomics research: https://hubs.li/Q02R3hc70

Unlock the potential of microbial genomics with long-read whole-genome sequencing! Whether for probiotic discovery or regulatory purposes, Clinical Microbiomics / CosmosID/ DNASense flexible sample-to-answer workflows provide contiguous, high-quality (QV50+) de novo annotated genomes suitable for any downstream applications. Besides our standard service which includes everything from DNA extraction to de novo assembly and functional gene annotation with full data access and detailed project reporting, add-on analyses include: - Ultra-high resolution phylogenomics (core-genome SNP analysis) - Prokaryote methylation pattern analysis (epigenetics) - Antimicrobial resistance profiling State-of-the-art long-read Q20+ DNA sequencing workflows using Oxford Nanopore Technologies improve genome contiguity for more accurate gene assignments, complete circular prokaryotic genomes, and highly contiguous fungal chromosomes. For more information on long-read microbial genomics: https://hubs.li/Q02R30jF0 or at https://hubs.li/Q02R2XXg0 #MicrobialGenomics #LongReadSequencing #OxfordNanopore #ClinicalMicrobiology #Epigenetics #GenomeAssembly

Advanced #microbiome stats and publication ready visualizations at your fingertips without having to code! Great job to the teams at Clinical Microbiomics and CosmosID !

The CosmosID-HUB team are excited to launch the Advanced Statistics Module to the software platform today. This a huge leap forward in lowering the barrier to entry for microbiome researchers to perform their own statistical analysis, without the need for coding experience. This new module is built on the robust MAASLIN2 framework and includes early access to MAASLIN3 (Beta), enabling users to leverage their study metadata even further and run more complex statistics with their microbiome profiles. Users will be able to: - Leverage continuous variables for correlative microbiome analysis - Use multivariate statistics to control for potential confounders - Use time series data to perform longitudinal analysis - Customize their statistical analysis via various parameters and metrics - Generate new and dedicated visualizations Head over to https://hubs.li/Q02R2W6c0 and book a demo with our BD team! #microbiome #metagenomics #statistics #metagenome #microbiota #maaslin